MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gyenes, M.
Right arrow Articles by Farb, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gyenes, M.
Right arrow Articles by Farb, D. H.

Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor

M Gyenes, Q Wang, TT Gibbs and DH Farb

Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Massachusetts 02118.

Whole-cell and patch-voltage clamp experiments were carried out on cultured chick spinal cord neurons to investigate the dependence of gamma-aminobutyric acid (GABA)A receptor function on intracellular phosphorylation factors. Without ATP in the intracellular solution, repeated application of 30 microM GABA results in a progressive decline (run-down) of the currents evoked by GABA in standard whole-cell recordings but not when the nystatin-perforated patch method is used. Run-down is also observed in outside-out excised patch recordings, indicating that any enzymatic factors required for run-down must be closely associated with the plasma membrane. Run-down is associated with decreases in both the maximum GABA-induced current and the GABA EC50. Inclusion of magnesium adenosine-5'-O-(3-thio)triphosphate in the intracellular buffer prevents the decline in the maximum GABA response but the GABA EC50 still decreases, resulting in a "run-up" of the response at low (3 microM) GABA concentrations. Run-down is use dependent, requiring repeated activation of the GABAA receptor by high (30 microM) GABA concentrations. However, use-independent run-down can be induced by the inclusion of alkaline phosphatase in the intracellular buffer. The response to 3 microM GABA does not normally run down, but run-down is observed when the response to 3 microM GABA is potentiated with pentobarbital or allopregnanolone, suggesting that run-down is consequence of GABA receptor activation and/or desensitization. Run-down of the potentiated GABA response can be prevented by addition of magnesium adenosine-5'-O-(3-thio)triphosphate to the intracellular solution. Strikingly, run-down results in a significant decrease in the potentiating effects of positive modulators, whereas the inhibitory effects of negative modulators such as pregnenolone sulfate and ZnCl2 are unchanged. The results demonstrate that phosphorylation factors have the capacity to control GABAA receptor pharmacology, affecting the potency and efficacy of GABA, the kinetics of GABAA receptor desensitization, and the sensitivity of the receptor to modulators such as steroids, benzodiazepines, and barbiturates.

Volume 46, Issue 3, pp. 542-549, 09/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. C. Gravielle, R. Faris, S. J. Russek, and D. H. Farb
GABA Induces Activity Dependent Delayed-onset Uncoupling of GABA/Benzodiazepine Site Interactions in Neocortical Neurons
J. Biol. Chem., June 3, 2005; 280(22): 20954 - 20960.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. J. Laschet, F. Minier, I. Kurcewicz, M. H. Bureau, S. Trottier, F. Jeanneteau, N. Griffon, B. Samyn, J. Van Beeumen, J. Louvel, et al.
Glyceraldehyde-3-Phosphate Dehydrogenase Is a GABAA Receptor Kinase Linking Glycolysis to Neuronal Inhibition
J. Neurosci., September 1, 2004; 24(35): 7614 - 7622.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. J. Hinkle and R. L. Macdonald
{beta} Subunit Phosphorylation Selectively Increases Fast Desensitization and Prolongs Deactivation of {alpha}1{beta}1{gamma}2L and {alpha}1{beta}3{gamma}2L GABAA Receptor Currents
J. Neurosci., December 17, 2003; 23(37): 11698 - 11710.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Tolstykh, S. Belugin, O. Tolstykh, and S. Mifflin
Responses to GABAA Receptor Activation Are Altered in NTS Neurons Isolated From Renal-Wrap Hypertensive Rats
Hypertension, October 1, 2003; 42(4): 732 - 736.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. R. Mellor and A. D. Randall
Synaptically Released Neurotransmitter Fails to Desensitize Postsynaptic GABAA Receptors in Cerebellar Cultures
J Neurophysiol, May 1, 2001; 85(5): 1847 - 1857.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. K. Meyer, C. Olenik, F. Hofmann, H. Barth, J. Leemhuis, I. Brunig, K. Aktories, and W. Norenberg
Regulation of Somatodendritic GABAA Receptor Channels in Rat Hippocampal Neurons: Evidence for a Role of the Small GTPase Rac1
J. Neurosci., September 15, 2000; 20(18): 6743 - 6751.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Fancsik, D. M. Linn, and J. G. Tasker
Neurosteroid Modulation of GABA IPSCs Is Phosphorylation Dependent
J. Neurosci., May 1, 2000; 20(9): 3067 - 3075.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. N. Connolly, J. T. Kittler, P. Thomas, J. M. Uren, N. J. Brandon, T. G. Smart, and S. J. Moss
Cell Surface Stability of gamma -Aminobutyric Acid Type A Receptors. DEPENDENCE ON PROTEIN KINASE C ACTIVITY AND SUBUNIT COMPOSITION
J. Biol. Chem., December 17, 1999; 274(51): 36565 - 36572.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. Kapur, K. F. Haas, and R. L. Macdonald
Physiological Properties of GABAA Receptors From Acutely Dissociated Rat Dentate Granule Cells
J Neurophysiol, May 1, 1999; 81(5): 2464 - 2471.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. S. Smith, Q. H. Gong, X. Li, M. H. Moran, D. Bitran, C. A. Frye, and F.-C. Hsu
Withdrawal from 3alpha -OH-5alpha -Pregnan-20-One Using a Pseudopregnancy Model Alters the Kinetics of Hippocampal GABAA-Gated Current and Increases the GABAA Receptor alpha 4 Subunit in Association with Increased Anxiety
J. Neurosci., July 15, 1998; 18(14): 5275 - 5284.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R.-Q. Huang and G. H. Dillon
Maintenance of Recombinant Type A gamma -Aminobutyric Acid Receptor Function: Role of Protein Tyrosine Phosphorylation and Calcineurin
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 243 - 255.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
J. W. Mozrzymas and E. Cherubini
Changes in Intracellular Calcium Concentration Affect Desensitization of GABAA Receptors in Acutely Dissociated P2-P6 Rat Hippocampal Neurons
J Neurophysiol, March 1, 1998; 79(3): 1321 - 1328.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Tanaka, H. Saito, and N. Matsuki
Inhibition of GABAA Synaptic Responses by Brain-Derived Neurotrophic Factor (BDNF) in Rat Hippocampus
J. Neurosci., May 1, 1997; 17(9): 2959 - 2966.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics